2016 has been a great year for gene therapy, and The Institute of Exponential Sciences has organised the D.N.A Congress in Utrecht to discuss how these exciting developments will impact on longevity. This event is a fantastic chance to learn about next-generation longevity therapies, and features heavy hitters such as Liz Parrish, Aubrey de Grey and Oliver Medvedik. Interested? Please go support the crowdfunding campaign today!
The National Institute of Aging (NIA) Interventions Testing Program (ITP) is the most rigorous program for testing the effects of drugs on the lifespan of mice, and the results are in from the latest round of testing involving 8 different drugs
The bacteria, archaea, viruses, fungi and protozoa living in the gut, collectively called the gut microbiome, have been linked to several diseases including obesity, heart disease, depression, type 2 diabetes, and rheumatoid arthritis. Does the microbiome cause the disease or does the disease cause the changed microbiome?
Following promising early results, BioViva USA Inc. is filing a patent for its dual telomere lengthening and muscle preserving gene therapy, in a bid to secure access to eventual affordable gene therapy